FHM LIFE Sciences Viii, L.P., 10% Owner at Entasis Therapeutics Holdings Inc. (ETTX), sold 50,000 shares at $5.00 ($250K) on 2020-01-09, disclosed to the SEC on 2020-01-13.
Open-market sale of $250k ETTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| APTX | BUY | 2018-06-26 | $2.4M | — | Filing → |